0.7300GBp+15.73%Mkt Cap: 4.21M GBpP/E: —Last update: 2026-05-13
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It …
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-0.94
PEG—
P/B0.70
P/S0.51
EV/EBITDA0.25
EV/Revenue-0.20
EPS (TTM)-0.03
EPS (Forward)-0.01
Cash Flow & Leverage
FCF Yield-38.44%
FCF Margin-20.41%
Operating CF391.47K GBp
CapEx (TTM)1.73M GBp
Net Debt/EBITDA0.60
Net Debt-3.69M GBp
Technical
SMA 501.081 (-32.4%)
SMA 2002.722 (-73.2%)
Beta0.01
S&P 52W Chg24.23%
Avg Vol (30d)6.79M
Avg Vol (10d)4.66M
Technical Indicators
RSI (14)37.4
MACD-0.1382
MACD Signal-0.1017
MACD Hist.-0.0365
BB Upper1.618 GBp
BB Middle1.021 GBp
BB Lower0.4254 GBp
BB Width116.71%
ATR (14)0.1921 GBp
Vol Ratio (20d)0.19x
52W Range
0.60001% of range15.00
52W High15.00 GBp
52W Low0.6000 GBp
Profitability
Gross Margin64.49%
EBITDA Margin-77.91%
Profit Margin-79.41%
Oper. Margin-671.64%
ROE-115.97%
ROA-52.66%
Revenue Growth-85.70%
Earnings Growth—
Balance Sheet
Debt/Equity—
Current Ratio2.23
Quick Ratio2.11
Book Value/Sh0.0100 GBp
Cash/Share0.0120 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.581.33M
Float268.41M
Insiders16.13%
Institutions16.70%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap4.21M GBp
Enterprise Value-1.56M GBp
Revenue (TTM)7.93M GBp
Gross Profit5.11M GBp
Net Income (TTM)-6.29M GBp
Revenue/Share0.0260 GBp
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees14
Last Price0.7300 GBp
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINGB0033278473